Teva Pharmaceuticals CEO Richard Francis reflects on company performance in 2024, drug pricing, getting more drugs to market and supply shortages of the drug Adderall.
He speaks to Bloomberg's Katie Griefeld from the JPMorgan Healthcare Conference.

RobCo CEO Roman Hölzl Talks $1 Billion Unicorn Valuation
07:43

US Attorney General Todd Blanche Talks Election Fraud Cases
17:08

Senior Fellow at Council on Foreign Relations Rebecca Patterson Talks "Too Much"
07:54